Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

DM
2019-03-14
AMPHAmphastar Pharmaceuticals, Inc.Shandell Jason B.Pres, GCS - Sale+OE$20.35-32,336176,028-16%-$657,930
D
2019-03-15
PFEPfizer IncJohnson Rady AEVPS - Sale+OE$41.13-8,70064,960-12%-$357,831
2019-03-14
BGNEBeigene, Ltd.Glazer Donald W.DirS - Sale$136.10-14,9734,145,0290%-$2,037,825
2019-03-15
OCULOcular Therapeutix, IncHeier Jeffrey S.DirP - Purchase$4.15+24,00024,000New+$99,600
2019-03-15
OCULOcular Therapeutix, IncGoldstein Michael H.Chief Medical OfficerP - Purchase$4.15+10,00013,686+271%+$41,500
ADM
2019-03-14
VCNXVaccinex, Inc.Friedberg AlbertDir, 10%P - Purchase$3.98+2,0005,850,9900%+$7,960
M
2019-03-14
VRCAVerrica Pharmaceuticals Inc.Davidson Matt10%S - Sale$12.26-11,6262,829,4030%-$142,561
DM
2019-03-14
VCNXVaccinex, Inc.Friedberg AlbertDir, 10%P - Purchase$3.98+2,0005,850,9900%+$7,960
2019-03-18
XCURExicure, Inc.Mirkin Chad A.Dir, 10%P - Purchase$2.40+1,00011,300,2600%+$2,400
2019-03-18
ATHXAthersys, Inc / NewLehmann William JrPres, COOS - Sale$1.53-15,000453,751-3%-$22,947
M
2019-02-21
ALKSAlkermes Plc.Wysenski NancyDirP - Purchase$33.09+4,3024,302New+$142,340
2019-03-14
CLVSClovis Oncology, Inc.Blair James CDirS - Sale$27.79-17,05623,544-42%-$473,986
D
2019-03-18
ATNXAthenex, Inc.Lau Johnson Yiu NamCEO, COB, 10%P - Purchase$12.52+4,0003,883,9440%+$50,080
DM
2019-03-14
VCNXVaccinex, Inc.Friedberg AlbertDir, 10%P - Purchase$3.98+2,0005,850,9900%+$7,960
DM
2019-03-14
ATNXAthenex, Inc.Trainor-Degirolamo SheldonDirS - Sale+OE$11.77-54,085611,333-8%-$636,581
D
2019-03-14
ZTSZoetis Inc.Lewis Clinton A. Jr.EVPS - Sale+OE$96.54-6,12550,917-11%-$591,308
2019-03-14
NATRNatures Sunshine Products IncWynnefield Partners Small Cap Value LP10%P - Purchase$10.44+1,6662,219,3750%+$17,385
M
2019-03-14
ATHXAthersys, Inc / NewHarrington John JExec Vice Pres, CSOS - Sale$1.55-15,000619,666-2%-$23,288
2019-03-15
VERUVeru Inc.Fisch HarryDir, 10%P - Purchase$1.47+3,0008,075,1210%+$4,410
2019-03-15
CRBPCorbus Pharmaceuticals Holdings, Inc.Hochman David PDirP - Purchase$6.98+2,000704,4000%+$13,958
2019-03-15
CLSDClearside Biomedical, Inc.Deignan Charles A.CFOP - Purchase$1.36+10,00076,356+15%+$13,600
2019-03-14
ASRTAssertio Therapeutics, IncBukofzer StanSVP, Chf Scitfc, Tech OfficerP - Purchase$4.13+5,0005,000New+$20,658
2019-03-14
ASRTAssertio Therapeutics, IncPeisert Daniel A.SVP, CFOP - Purchase$4.18+6,00021,356+39%+$25,069
D
2019-03-13
GWPHGw Pharmaceuticals PlcMackey Catherine JDirS - Sale+OE$14.39-88819,284-4%-$12,778
M
2019-03-11
STMLStemline Therapeutics IncBergstein IvanCEOS - Sale$11.11-57,2242,662,127-2%-$635,630
M
2019-03-11
STMLStemline Therapeutics IncHoberman KennethCOOS - Sale$11.11-26,082755,696-3%-$289,702
M
2019-03-11
STMLStemline Therapeutics IncGionco DavidChief Accounting OfficerS - Sale$11.11-14,022224,938-6%-$155,753
2019-03-13
DRRXDurect CorpSaxe Jon SDirP - Purchase$0.82+3,70072,810+5%+$3,021
2019-03-13
DRRXDurect CorpSaxe Jon SDirP - Purchase$0.82+21,30041,300+107%+$17,480
2019-03-14
KALVKalvista Pharmaceuticals, Inc.Crockett Thomas AndrewCEOS - Sale$30.16-3,000268,510-1%-$90,484
2019-03-14
ESPREsperion Therapeutics, Inc.Biotech Target N V10%P - Purchase$49.89+50,0003,522,964+1%+$2,494,355
2019-03-14
FGENFibrogen IncYu K PeonyChief Medical OfficerS - Sale$56.30-9,145182,440-5%-$514,864
2019-03-14
ABBVAbbvie Inc.Schumacher Laura JVice COBS - Sale$80.00-25,000139,838-15%-$2,000,000
M
2019-03-13
ALRNAileron Therapeutics IncNovartis Bioventures Ltd10%S - Sale$2.06-190,3382,206,544-8%-$391,445
M
2019-03-13
ZGNXZogenix, Inc.Hawley RogerDirS - Sale$52.99-60,00010,575-85%-$3,179,476
D
2019-03-15
ATNXAthenex, Inc.Lau Johnson Yiu NamCEO, COB, 10%P - Purchase$11.77+12,0003,879,9440%+$141,240
D
2019-03-13
CARACara Therapeutics, Inc.Mohindru ManiCFO, Chief Strategy OfficerS - Sale+OE$19.12-16,0418,026-67%-$306,704
D
2019-03-13
TCDATricida, Inc.Otto Dawn ParsellSVP, Clinical DevelopmentS - Sale+OE$25.00-2,0000-100%-$50,000
DM
2019-03-13
TCDATricida, Inc.Lockey ClaireChief Dev. Officer, SVPS - Sale+OE$25.01-13,4940-100%-$337,500
M
2019-03-13
RYTMRhythm Pharmaceuticals, Inc.Gottesdiener Keith MichaelCEO, PresS - Sale$30.06-9,288516,632-2%-$279,182
M
2019-03-13
QUREUniqure N.V.Kapusta Matthew CCEO, CFO, MDS - Sale$63.96-67,376423,230-14%-$4,309,297
2019-03-13
LGNDLigand Pharmaceuticals IncAryeh JasonDirP - Purchase$112.51+202115,7370%+$22,727
2019-03-13
LGNDLigand Pharmaceuticals IncHiggins John LCEOP - Purchase$114.29+2,500141,399+2%+$285,725
2019-03-15
CRBPCorbus Pharmaceuticals Holdings, Inc.Jenkins John KennethDirP - Purchase$6.98+1,0001,000New+$6,978
2019-03-14
CRBPCorbus Pharmaceuticals Holdings, Inc.Millian Craig StuartChief Commercial OfficerP - Purchase$6.85+5,0005,000New+$34,259
2019-03-14
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$2.45+250,000212,829,6330%+$612,918
M
2019-03-12
SYRSSyros Pharmaceuticals, Inc.Arch Venture Fund Vii, L.P.10%S - Sale$7.83-167,5034,305,051-4%-$1,312,380
D
2019-03-14
ALKSAlkermes Plc.Landine Michael JSVP, Corp Dev., Alkermes, Inc.S - Sale+OE$33.05-25,000185,122-12%-$826,373
DM
2019-03-12
ALKSAlkermes Plc.Pops Richard FDir, CEO, Alkermes plcS - Sale+OE$33.32-60,000716,433-8%-$1,998,932
D
2019-03-13
MRKMerck & Co., Inc.Frazier Kenneth CCOB, Pres, CEOS - Sale+OE$82.00-18,725801,725-2%-$1,535,454
D
2019-03-12
IONSIonis Pharmaceuticals IncParshall B LynneDirS - Sale+OE$75.00-8,33452,677-14%-$625,050
2019-03-13
ELANElanco Animal Health IncHoover R DavidDirP - Purchase$31.43+20,00032,716+157%+$628,586
2019-01-23
BLPHBellerophon Therapeutics, Inc.Venrock Associates IV L P10%P - Purchase$0.70+142,8577,529,020+2%+$100,000
2019-01-23
BLPHBellerophon Therapeutics, Inc.Venrock Associates IV L P10%P - Purchase$0.70+142,8577,529,020+2%+$100,000
D
2019-03-12
BHVNBiohaven Pharmaceutical Holding Co Ltd.Tilton JohnChief Commercial OfficerS - Sale+OE$50.11-10,0001,614-86%-$501,100
M
2019-03-12
BHVNBiohaven Pharmaceutical Holding Co Ltd.Coric VladCEOS - Sale$50.09-100,0002,333,821-4%-$5,008,913
M
2019-03-13
VTGNVistagen Therapeutics, Inc.Saxe Jon SDirP - Purchase$1.26+20,00023,251+615%+$25,288
M
2019-03-12
CARACara Therapeutics, Inc.Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R, DS - Sale$18.65-20,000122,779-14%-$373,020
2019-03-13
ABTAbbott LaboratoriesBird RogerSVPS - Sale$79.06-9,18859,807-13%-$726,416
M
2019-03-08
ENDVEndonovo Therapeutics, Inc.Collier Alan BrianCEOP - Purchase$0.02+21,00021,814,1230%+$413
2019-03-13
XCURExicure, Inc.Mirkin Chad A.Dir, 10%P - Purchase$2.50+2,20011,299,2600%+$5,500
2019-03-14
ESPREsperion Therapeutics, Inc.Mayleben Timothy MPres, CEOP - Purchase$48.73+5,00051,163+11%+$243,650
2019-03-12
ESPREsperion Therapeutics, Inc.Newton Roger SDirS - Sale$50.06-25,000548,726-4%-$1,251,500
DM
2019-03-11
ATNXAthenex, Inc.Zhang Song-YiDirS - Sale+OE$11.88-120,0535,197,668-2%-$1,425,830
2019-03-13
OCULOcular Therapeutix, IncLindstrom Richard L MdDirP - Purchase$4.33+56,441100,000+130%+$244,390
D
2019-03-13
ATNXAthenex, Inc.Trainor-Degirolamo SheldonDirS - Sale+OE$11.77-45,915665,418-6%-$540,420
D
2019-03-13
BMRNBiomarin Pharmaceutical IncBienaime Jean JacquesCEOS - Sale+OE$93.42-3,000510,042-1%-$280,253
2019-03-14
CRBPCorbus Pharmaceuticals Holdings, Inc.White BarbaraChief Medical OfficerP - Purchase$6.47+4,638184,159+3%+$29,994
2019-03-14
CRBPCorbus Pharmaceuticals Holdings, Inc.Moran Sean F.CFOP - Purchase$6.67+1,500349,5100%+$10,005
2019-03-14
CRBPCorbus Pharmaceuticals Holdings, Inc.Cohen YuvalCEOP - Purchase$6.49+1,53063,190+2%+$9,930
D
2019-03-12
TEVATeva Pharmaceutical Industries LtdStark David MatthewEVP GCS - Sale+OE$15.82-2,4442,974-45%-$38,664
D
2019-03-12
TEVATeva Pharmaceutical Industries LtdO'Grady Brendan P.EVP, North America CommercialS - Sale+OE$15.67-7381,388-35%-$11,568
D
2019-03-12
TEVATeva Pharmaceutical Industries LtdNazzi GianfrancoEVP, Growth Markets CommercialS - Sale+OE$15.69-3258,450-4%-$5,099
D
2019-03-12
TEVATeva Pharmaceutical Industries LtdGriffin Deborah AChief Accounting OfficerS - Sale+OE$15.67-9530-100%-$14,938
D
2019-03-12
TEVATeva Pharmaceutical Industries LtdDethlefs SvenEVP Global Marketing, PortfoliS - Sale+OE$15.67-6478,602-7%-$10,142
D
2019-03-12
TEVATeva Pharmaceutical Industries LtdDaniell RichardEVP, European CommercialS - Sale+OE$15.69-7150-100%-$11,218
DM
2019-03-12
ANIPAni Pharmaceuticals IncSchrepfer Robert WSVP - New Bus Dev, Spec SalesS - Sale+OE$64.44-11,79647,842-20%-$760,168
2019-03-12
DRRXDurect CorpArenberg MichaelCFOP - Purchase$0.80+10,00024,426+69%+$7,990
DM
2019-03-11
BMRNBiomarin Pharmaceutical IncBienaime Jean JacquesCEOS - Sale+OE$90.06-9,000510,042-2%-$810,550
2019-03-08
AMARAmarillo Biosciences IncChen Stephen TPres,COB,CEO,CFO, 10%P - Purchase$0.36+1,0006,773,3600%+$360
2019-03-11
ELANElanco Animal Health IncUrbanek David AlanSee RemarksP - Purchase$0.00+2,02114,000+17%+$0
M
2019-03-11
VRCAVerrica Pharmaceuticals Inc.Davidson Matt10%S - Sale$11.55-25,0452,841,029-1%-$289,317
2019-03-11
ELANElanco Animal Health IncSimmons Jeffrey NPresiident, CEO, DirP - Purchase$0.00+37,301129,538+40%+$0
2019-03-11
ELANElanco Animal Health IncSchacht Aaron LSee RemarksP - Purchase$0.00+1,22713,924+10%+$0
2019-03-11
ELANElanco Animal Health IncKinard David SSee RemarksP - Purchase$0.00+7,97722,569+55%+$0
2019-03-11
ELANElanco Animal Health IncCabral Ramiro MartinSee RemarksP - Purchase$0.00+1,22712,741+11%+$0
2019-03-11
ELANElanco Animal Health IncHoover R DavidDirP - Purchase$0.00+92012,716+8%+$0
M
2019-03-11
AKAOAchaogen, Inc.Duggan Robert W10%S - Sale$0.60-2,354,0077,035,727-25%-$1,422,348
2019-03-11
EBSEmergent Biosolutions Inc.Havey AdamEVP, Business OperationsS - Sale$56.93-2,43032,240-7%-$138,340
M
2019-02-25
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPresP - Purchase$0.02+56,00026,759,8970%+$1,151
2019-03-13
VERUVeru Inc.Fisch HarryDir, 10%P - Purchase$1.47+3,5008,072,1210%+$5,145
2019-03-12
ZTSZoetis Inc.Chen Heidi C.EVPS - Sale$95.49-15,71013,963-53%-$1,500,148
2019-03-12
NATRNatures Sunshine Products IncWynnefield Partners Small Cap Value LP10%P - Purchase$9.52+5,8342,217,7090%+$55,517
2019-03-12
FLXNFlexion Therapeutics IncClayman Michael D.Pres, CEOP - Purchase$12.36+4,046798,205+1%+$50,009
2019-03-11
CALACalithera Biosciences, Inc.Orford KeithChief Medical OfficerS - Sale$6.00-1,56511,249-12%-$9,390
2019-03-11
APLSApellis Pharmaceuticals, Inc.Morningside Venture Investments Ltd10%P - Purchase$17.00+441,17612,015,802+4%+$7,499,992
2019-03-12
LLYLilly Eli & CoFry Stephen FSVP, HR, DiversityS - Sale$123.16-14,847109,835-12%-$1,828,557
A
2018-11-14
MNKDMannkind CorpTross Stuart AEVP, Chief People OfficerP - Purchase$1.77+14,12477,084+22%+$24,999
A
2018-11-14
MNKDMannkind CorpKendall David MChief Medical OfficerP - Purchase$1.77+2,8242,824New+$4,998
A
2018-11-14
MNKDMannkind CorpMcCauley PatrickChief Commercial OfficerP - Purchase$1.77+14,12445,165+46%+$24,999
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top